News & Updates

Show Multimedia Only
Antenatal vitamin D supplementation may curb risk of infant eczema

Antenatal vitamin D supplementation may curb risk of infant eczema

01 Aug 2022
HBV coinfection among TB patients higher than expected

HBV coinfection among TB patients higher than expected

01 Aug 2022

Coinfection with hepatitis B virus (HBV) among patients with tuberculosis (TB) appears to be 38-percent to 450-percent more prevalent than published estimates from the Polaris group of region-specific overall HBV prevalence, suggest the results of a meta-analysis.

HBV coinfection among TB patients higher than expected

01 Aug 2022
Men with multiple sclerosis at risk of erectile dysfunction

Men with multiple sclerosis at risk of erectile dysfunction

01 Aug 2022

Adult men with multiple sclerosis (MS) are more likely to develop erectile dysfunction (ED), indicating that MS is a potential predictor for ED occurrence, suggest the results of a meta-analysis.

Men with multiple sclerosis at risk of erectile dysfunction

01 Aug 2022
Timing of liquid LT4 intake doesn’t impact bioavailability

Timing of liquid LT4 intake doesn’t impact bioavailability

01 Aug 2022 byElvira Manzano

Bioavailability studies presented at ENDO 2022 showed that patients with hypothyroidism can safely take the liquid formulations of levothyroxine (LT4) 15 or 30 minutes before meals, without having to worry about food effect on bioavailability.

Timing of liquid LT4 intake doesn’t impact bioavailability

01 Aug 2022
HK’s first territory-wide long COVID study to inform follow-up care

HK’s first territory-wide long COVID study to inform follow-up care

01 Aug 2022 byChristina Lau

Researchers at the Chinese University of Hong Kong (CUHK) have rolled out the city’s first territory-wide study of long COVID to inform multidisciplinary follow-up care for thousands of COVID-19 survivors. Participants are also invited to a second-phase 3-year prospective study of the impact of gut dysbiosis on long COVID symptoms and the potential role of gut microbiome modulation in treatment of long COVID.

HK’s first territory-wide long COVID study to inform follow-up care

01 Aug 2022